X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (117) 117
Book / eBook (87) 87
Newspaper Article (38) 38
Publication (16) 16
Magazine Article (12) 12
Dissertation (11) 11
Trade Publication Article (7) 7
Book Review (6) 6
Conference Proceeding (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (61) 61
humans (58) 58
female (43) 43
male (41) 41
middle aged (34) 34
aged (31) 31
oncology (29) 29
cancer (25) 25
adult (24) 24
hematology, oncology and palliative medicine (22) 22
history (22) 22
chemotherapy (21) 21
clinical trials (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (19) 19
research (18) 18
treatment outcome (16) 16
aged, 80 and over (14) 14
fluorouracil - administration & dosage (14) 14
deoxycytidine - analogs & derivatives (13) 13
kaplan-meier estimate (13) 13
cancer therapies (12) 12
care and treatment (12) 12
deoxycytidine - administration & dosage (12) 12
disease-free survival (12) 12
prognosis (12) 12
studies (12) 12
metastasis (11) 11
antineoplastic combined chemotherapy protocols - adverse effects (10) 10
fluorouracil (10) 10
medical research (10) 10
medicine (10) 10
medicine, general & internal (10) 10
product development (10) 10
stomach neoplasms - drug therapy (10) 10
therapy (10) 10
time factors (10) 10
united kingdom (10) 10
young adult (10) 10
abridged index medicus (9) 9
analysis (9) 9
aufsatzsammlung (9) 9
capecitabine (9) 9
colorectal cancer (9) 9
engineering, mechanical (9) 9
fluorouracil - analogs & derivatives (9) 9
follow-up studies (9) 9
health aspects (9) 9
science (9) 9
surgery (9) 9
drug therapy (8) 8
neoplasm staging (8) 8
patients (8) 8
survival (8) 8
adenocarcinoma - drug therapy (7) 7
case-control studies (7) 7
children (7) 7
cisplatin - administration & dosage (7) 7
drug administration schedule (7) 7
education (7) 7
esophageal neoplasms - drug therapy (7) 7
great britain (7) 7
infection (7) 7
multidisciplinary sciences (7) 7
proportional hazards models (7) 7
research article (7) 7
stomach neoplasms - mortality (7) 7
survival rate (7) 7
adenocarcinoma (6) 6
adenocarcinoma - mortality (6) 6
adolescent (6) 6
antimitotic agents (6) 6
antineoplastic agents (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
article (6) 6
chemoradiotherapy (6) 6
double-blind method (6) 6
esophageal neoplasms - mortality (6) 6
hiv (6) 6
hospitals (6) 6
immunology (6) 6
internal medicine (6) 6
leucovorin (6) 6
metaanalysis (6) 6
oxaliplatin (6) 6
quality-of-life (6) 6
tumors (6) 6
usage (6) 6
1st-line therapy (5) 5
adenocarcinoma - pathology (5) 5
adjuvant chemotherapy (5) 5
antineoplastic agents - therapeutic use (5) 5
articles (5) 5
bevacizumab (5) 5
biomarkers (5) 5
colorectal neoplasms - drug therapy (5) 5
electronic books (5) 5
esophageal neoplasms - pathology (5) 5
iii trial (5) 5
intention to treat analysis (5) 5
management (5) 5
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (31) 31
Gerstein Science - Stacks (14) 14
UTL at Downsview - May be requested (14) 14
Online Resources - Online (10) 10
University Archives - Archives (6) 6
UofT at Mississauga - Stacks (6) 6
St. Michael's College (John M. Kelly) - 2nd Floor (5) 5
Engineering & Comp. Sci. - Stacks (4) 4
OISE - Stacks (4) 4
Regis College - Stacks (4) 4
St. Michael's College (John M. Kelly) - 3rd Floor (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Law (Bora Laskin) - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Knox College (Caven) - Stacks (2) 2
Knox College (Caven) - Storage (2) 2
Pontifical Inst. Mediaeval Studies - Library use only (2) 2
St. Augustine's Seminary - Stacks (2) 2
Trinity College (John W Graham) - Stacks (2) 2
Trinity College (John W Graham) - Storage (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Victoria University Emmanuel College - Storage (2) 2
Astronomy & Astrophysics - Ask at library (1) 1
Gerstein Science - Missing (1) 1
Institute for Christian Studies - Stacks (1) 1
Map & Data - Map Collection (1) 1
Massey College (Robertson Davies) - Rare Book (1) 1
New College (Ivey) - Stacks (1) 1
OISE - Curriculum Resources (1) 1
Royal Ontario Museum - Periodical Stacks (1) 1
Royal Ontario Museum - Reference (1) 1
St. Augustine's Seminary - Reference (1) 1
Thomas Fisher Rare Book - May be requested at Fisher (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT at Mississauga - May be requested in 6-10 wks (1) 1
Victoria University CRRS - Rare Book (1) 1
Victoria University E.J. Pratt - Reference (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (272) 272
Dutch (1) 1
French (1) 1
German (1) 1
Japanese (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2006, Multilingual matters, ISBN 1853598682, Volume 134, xii, 217
Book
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1224 - 1235
Summary Background VEGFR-2 has a role in gastric cancer pathogenesis and progression. We assessed whether ramucirumab, a monoclonal antibody VEGFR-2... 
Hematology, Oncology and Palliative Medicine | SUPPORTIVE CARE | ONCOLOGY | BEVACIZUMAB | CLINICAL-TRIALS | GROWTH | 2ND-LINE CHEMOTHERAPY | OPEN-LABEL | 1ST-LINE THERAPY | COMBINATION | CANCER | III TRIAL | Confidence Intervals | Adenocarcinoma - pathology | Prognosis | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Stomach Neoplasms - pathology | Esophageal Neoplasms - pathology | Dose-Response Relationship, Drug | Esophageal Neoplasms - mortality | Adult | Female | Remission Induction - methods | Paclitaxel - administration & dosage | Double-Blind Method | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Esophagogastric Junction - pathology | Paclitaxel - adverse effects | Treatment Outcome | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Disease-Free Survival | Maximum Tolerated Dose | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged | Esophageal Neoplasms - drug therapy | Stomach Neoplasms - mortality | Adenocarcinoma - mortality | Antimitotic agents | Care and treatment | Hospitals | Clinical trials | Monoclonal antibodies | Product development | Antineoplastic agents | Vascular endothelial growth factor | Esophageal cancer
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10073, pp. 1011 - 1024
Summary Background The ESPAC-3 trial showed that adjuvant gemcitabine is the standard of care based on similar survival to and less toxicity than adjuvant... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | THERAPY | ADENOCARCINOMA | CHEMORADIOTHERAPY | FOLINIC ACID | MODEL | CHEMOTHERAPY | Capecitabine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Carcinoma, Pancreatic Ductal - surgery | Antimetabolites, Antineoplastic - administration & dosage | Pancreatic Neoplasms - drug therapy | Aged, 80 and over | Adult | Carcinoma, Pancreatic Ductal - mortality | Deoxycytidine - adverse effects | Female | Pancreatic Neoplasms - mortality | Chemotherapy, Adjuvant | Deoxycytidine - administration & dosage | Pancreatic Neoplasms - surgery | Kaplan-Meier Estimate | Treatment Outcome | Carcinoma, Pancreatic Ductal - drug therapy | Capecitabine - adverse effects | Antimetabolites, Antineoplastic - adverse effects | Aged | Deoxycytidine - analogs & derivatives | Antimitotic agents | Cancer patients | Care and treatment | Pancreatic cancer | Clinical trials | Product development | Metastasis | Comparative analysis | Antineoplastic agents | Studies | Antigens | Chemotherapy | Acids | Pragmatism | Pharmaceutical industry | Cancer therapies | Abdomen | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10018, pp. 545 - 557
Summary Background Nanoliposomal irinotecan showed activity in a phase 2 study in patients with metastatic pancreatic ductal adenocarcinoma previously treated... 
Internal Medicine | PLUS GEMCITABINE | SURVIVAL | 5-FLUOROURACIL | MEDICINE, GENERAL & INTERNAL | ADENOCARCINOMA | 2ND-LINE CHEMOTHERAPY | OXALIPLATIN | PEP02 | DOCETAXEL | CARCINOMA | FOLFIRI | Leucovorin - administration & dosage | Humans | Middle Aged | Male | Fatigue - chemically induced | Diarrhea - chemically induced | Pancreatic Neoplasms - drug therapy | Neoplasm Metastasis | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Camptothecin - administration & dosage | Carcinoma, Pancreatic Ductal - mortality | Deoxycytidine - adverse effects | Female | Pancreatic Neoplasms - mortality | Neutropenia - chemically induced | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Carcinoma, Pancreatic Ductal - drug therapy | Irinotecan | Vomiting - chemically induced | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Liposomes | Deoxycytidine - analogs & derivatives | Antimitotic agents | Medical colleges | Pancreatic cancer | Leucovorin | Product development | Research institutes | Metastasis | Antineoplastic agents | Analysis | Antigens | Chemotherapy | Medical prognosis | Clinical trials | Drug dosages | Cancer therapies | Tumors | Adenocarcinoma | Slopes | Therapy | Gemcitabine | Toxicity | Metastases | Nanoparticles | Randomization | Motivation | Vomiting | Safety management | Toxic diseases | Neutropenia | Folinic acid | Lymphatic system | Medical treatment | Diarrhea | FDA approval | Survival | Patients | Acids | Equivalence | Interactive systems
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 12, pp. 1225 - 1233
Journal Article
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 6, pp. 601 - 611
Journal Article